KYORIN Pharmaceutical Co., Ltd. (TYO:4569)
Japan flag Japan · Delayed Price · Currency is JPY
1,171.00
+16.00 (1.39%)
Aug 25, 2026, 3:30 PM JST

KYORIN Pharmaceutical Cash Flow Statement

Millions JPY. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
4,45112,7707,0196,9065,216
Depreciation & Amortization
4,6634,6034,2903,8403,714
Loss (Gain) From Sale of Assets
481279027232
Loss (Gain) From Sale of Investments
-368305-993-674320
Loss (Gain) on Equity Investments
-35-3812--25
Other Operating Activities
-2,855-1,640-3,5811,397-1,238
Change in Accounts Receivable
241158-439-5,621-1,226
Change in Inventory
-2,059-12,330-5,444-5,809-3,633
Change in Accounts Payable
-1,0761,2523193,0853,875
Change in Other Net Operating Assets
3,371-1,701276-1,388-689
Operating Cash Flow
6,3813,5061,5492,0086,346
Operating Cash Flow Growth
82.00%126.34%-22.86%-68.36%22.30%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-3,864-5,697-5,778-6,330-2,444
Sale of Property, Plant & Equipment
13342-100-
Divestitures
41-921--
Sale (Purchase) of Intangibles
-112-596-468-3,075-246
Investment in Securities
2,262-522,6453,281317
Other Investing Activities
-104-20-507-251-187
Investing Cash Flow
-1,644-6,323-3,187-6,275-2,560

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Long-Term Debt Issued
50020,000---
Total Debt Issued
50020,000---
Short-Term Debt Repaid
-4,800-2,700---
Long-Term Debt Repaid
-217-10,200-200-200-200
Total Debt Repaid
-5,017-12,900-200-200-200
Net Debt Issued (Repaid)
-4,5177,100-200-200-200
Common Dividends Paid
-3,303-3,015-3,013-3,015-3,767
Other Financing Activities
-136-133-134-148-145
Financing Cash Flow
-7,9563,952-3,347-3,363-4,112

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
--87241139
Miscellaneous Cash Flow Adjustments
---31-831
Net Cash Flow
-3,2191,135-4,929-7,472-186

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
2,517-2,191-4,229-4,3223,902
Free Cash Flow Growth
----247.77%
Free Cash Flow Margin
1.99%-1.68%-3.54%-3.82%3.70%
Free Cash Flow Per Share
43.81-38.14-73.69-75.4268.09
Levered Free Cash Flow
1,270-5,979-3,378-10,3463,176
Unlevered Free Cash Flow
1,429-5,871-3,336-10,3043,218

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
254173666666
Cash Income Tax Paid
2,8651,3172,9752,0651,248
Change in Working Capital
477-12,621-5,288-9,733-1,673